R&D
Reuters Pharma USA 2024 – Meruno Perugini
Innovation in pharma comes in many forms, but at the end of the day …
26 April, 2024
18699 items found
Market Access
Deep Dive: Market Access 2024
In this edition of Deep Dive, Unpacking complex choreography in the …
26 April, 2024
News
Owlstone secures $6.5M for breath-based diagnostics for infectious disease
Owlstone Medical has secured a $5 million equity investment and …
26 April, 2024
Patients
Spotlight on kidney disease: Driving change for patients
Katherine Forbes, director of innovation and enterprise at Kidney …
26 April, 2024
News
ETH develops AI algorithm for drug discovery based on 3D protein surface
Chemists at ETH Zurich have developed a new computer process that …
26 April, 2024
News
Moderna banks on OpenAI to accelerate mRNA research
In an ambitious move, Moderna has teamed up with OpenAI, the …
26 April, 2024
R&D
Partner Content
9th Microbiome Movement Drug Development Summit
Back for its 9th consecutive year and gathering over 250 leaders in …
25 April, 2024
R&D
Is precision psychiatry possible?
Anyone who has taken a psychiatric medication knows that the status …
25 April, 2024
R&D
Emergence of ADCs as the “hot, new technology”
The recent acquisition of ImmunoGen by AbbVie, which followed the …
25 April, 2024
News
Endeavor raises $132.5m for fibrosis, cancer drugs
Endeavor BioMedicines has completed a third round financing, raising …
24 April, 2024
News
Alzheimer’s drug Leqembi moves forward, still in low gear
Biogen has given an update on the rollout of its Eisai-partnered …
24 April, 2024
News
Roche says it has shed 20% of NMEs from its pipeline
Roche chief executive Thomas Schinecker said today that one in five …
24 April, 2024
News
Moderna banks on OpenAI to accelerate mRNA research
In an ambitious move, Moderna has teamed up with OpenAI, the artificial intelligence company behind ChatGPT, to furthe
Digital
Sponsored
Innovation as Strategy: Enabling life sciences of the future
Explore “Innovation as Strategy” framework, providing a guide for employing innovative strategies in life sciences.
Market Access
Deep Dive: Market Access 2024
In this edition of Deep Dive, Unpacking complex choreography in the biologics patent dance, Alexion examines the urgent need for accelerated access programmes for rare disease treatments, and Putna
Sales & Marketing
Sponsored
How doctors are interacting with content in 10 data trends
It will come as no surprise to anyone in the healthcare space that doctors today are under an inordinate amount of pressure.
Oncology
Sponsored
Patient Centricity to Integration: Enhancing Cancer Outcomes
We are living in an era of unprecedented advances in cancer treatments with transformative therapies being regularly approved.
R&D
Partner Content
9th Microbiome Movement Drug Development Summit
The Home of Accelerating Microbial-Based Drug Development
Patients
Partner Content
The PM Society – Giving Back
The PM Society is a not-for-profit organisation with 40 years of Giving Back.
